94% of Companies Still Can't Show AI's EBITDA Impact

AI’s EBITDA impact remains elusive for the vast majority of companies, even as nearly every earnings call now mentions artificial intelligence. For investment research, credit, and PE/VC teams evaluating a company’s AI narrative, distinguishing genuine financial leverage from strategic messaging has become a critical diligence skill.

---

Key Takeaways

AI’s EBITDA impact separates a small minority of companies, averaging 20% EBITDA uplift and three dollars returned per dollar invested, from the 94% still unable to show measurable financial value.

• 94% of companies have yet to create meaningful financial value from AI investment

• A small cohort of 20 companies averaged a 20% EBITDA uplift from AI transformations.

• These leaders generate roughly $3 of incremental EBITDA for every $1 invested in AI.

• Two-thirds of top performers concentrated AI efforts on three or fewer business domains.

The Gap Between AI Spending And Results

Most companies now mention AI in earnings calls. Very few can show it in earnings. According to 2026 survey of more than 1,700 executives, 94% of businesses have yet to create meaningful financial value from AI investment, despite years of spending and strategic messaging.

This gap between narrative and numbers is well documented elsewhere too. A recent analysis of why AI spending isn’t paying off yet points to underlying architecture and integration issues, not a lack of ambition, as the primary constraint.

Meanwhile, a small subset of companies has quietly converted AI into real profit. Their results are instructive precisely because they are the exception, not the rule.

Distinguishing the two groups requires looking past the earnings-call language entirely.

What Separates AI’s EBITDA Winners From Others

Review of 20 leading companies found an average EBITDA uplift of 20%, alongside roughly $3 of incremental EBITDA generated for every $1 invested. These are not marginal gains; they represent a meaningfully different return profile from the broader market.

Investment levels among this cohort varied but scaled proportionately with the returns claimed, reinforcing that the outcome tracked the input rather than a lucky outlier result. A company reporting outsized AI returns on minimal disclosed investment deserves added scrutiny for that reason alone.

Structuring diligence around this pattern is where AI and automation assessment work increasingly adds value, since verifying investment-to-outcome ratios requires more than reading a press release.

The number that matters is not spend. It is spend relative to what actually changed on the income statement.

Why Narrow Focus Beats Enterprise-Wide AI Rollouts

What separates the minority is instructive for anyone assessing a company’s AI narrative. These companies concentrated on two or three business domains at most, rather than claiming AI impact across the enterprise, a sign of genuine leverage rather than diffuse experimentation.

Two-thirds of the studied cohort achieved their results using three or fewer focus areas. Instead of spreading resources thin, they built integrated systems combining multiple technologies and operational changes, not single point tools.

This mirrors a broader theme already explored in where private equity finds alpha as AI becomes table stakes, particularly within TMT, where the temptation to claim AI impact everywhere is strongest and the evidence for it is often weakest.

Breadth of claim and depth of proof tend to move in opposite directions.

How To Evaluate A Company’s AI Claims

They became cash accretive within one to two years, even as full value took two to four years to materialize, offering an early, checkable signal long before the complete case unfolds. That timeline itself is a useful diligence marker.

For investors and analysts, the distinction is no longer whether a company discusses AI, but whether its claims meet this evidentiary bar. A thorough investment research process should treat AI narrative with the same skepticism applied to any other unverified growth claim.

PE/VC support teams evaluating potential targets or portfolio companies can apply the same framework: ask which two or three domains carry the claimed impact, and ask for the cash-accretion timeline specifically.

Narrative alone no longer justifies premium valuation assumptions. The evidence, or its absence, is now readily checkable.

FAQ

When does AI investment typically become cash accretive for top-performing companies?

Top-performing companies in McKinsey’s study became cash accretive within one to two years of their AI transformation, even though the full financial case typically took two to four years to fully materialize. (Source: McKinsey)

Can a company claim AI-driven EBITDA growth across its entire enterprise credibly?

Broad, enterprise-wide AI claims are a weaker signal than narrow ones. Two-thirds of McKinsey’s top-performing cohort achieved their results using three or fewer focus areas, suggesting concentrated deployment, not enterprise-wide rollout, is what actually drives EBITDA impact. (Source: McKinsey)

Who should be most skeptical of broad AI narrative claims on earnings calls?

Analysts and investors covering companies that describe AI impact across many business functions simultaneously should apply the most scrutiny, since that pattern historically correlates with diffuse experimentation rather than measurable financial return.

Is a 94% failure rate to show AI value a sign AI investment isn’t working?

Not necessarily. A minority of companies are generating substantial AI-driven EBITDA gains, roughly $3 for every $1 invested among top performers, which indicates the technology can work; the 94% figure instead points to an execution and focus problem rather than a fundamental limitation of AI itself. (Source: TechTimes, citing McKinsey)